Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: A multicenter trial

Identifieur interne : 009F10 ( Main/Exploration ); précédent : 009F09; suivant : 009F11

Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: A multicenter trial

Auteurs : Carol Devine [Royaume-Uni] ; Ba Hons [Royaume-Uni] ; Charles Mccollum [Royaume-Uni]

Source :

RBID : ISTEX:BDA3067742E82F2B63F724F14D558E2130C262CF

Abstract

Background: Dacron (polyester fiber) was largely abandoned for femoropopliteal bypass grafts 30 years ago because saphenous vein achieved better patencies. However, in patients taking aspirin, patency in above-knee femoropopliteal bypass grafts has recently been shown to be equivalent to that with saphenous vein. We compared heparin-bonded Dacron (HBD) and polytetrafluoroethylene (PTFE) in a randomized multicenter trial including below-knee popliteal or tibioperoneal trunk bypass graft where the long saphenous vein was absent or inadequate. Methods: Over 28 months, 209 patients undergoing femoropopliteal bypass grafts (180 above-knee, 29 below-knee) were randomized to HBD (n = 106) or PTFE (n = 103). Each patient was given aspirin (300 mg/d) before surgery, and this continued unless the patient had intolerance to the aspirin. Results: The mean follow-up was 42 months (range, 28-55). Fifteen (7.1%) patients died with patent grafts, and three (1.4%) infected grafts were removed. Patency (measured with Kaplan-Meier survival analysis) at 1, 2, and 3 years for HBD was 70%, 63%, and 55% compared with 56%, 46%, and 42%, respectively, for PTFE (P =.044). A total of 67 secondary interventions were performed on 48 thrombosed grafts; long-term patency was achieved in only three. Risk factors for arterial disease did not significantly influence patency. Amputations have been performed in 23 patients, six after HBD and 17 after PTFE bypass grafts (P =.015). Conclusions: HBD achieved better patency than PTFE, which carried a high risk of subsequent amputation. (J Vasc Surg 2001;33:533-9.)

Url:
DOI: 10.1067/mva.2001.113578


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: A multicenter trial</title>
<author>
<name sortKey="Devine, Carol" sort="Devine, Carol" uniqKey="Devine C" first="Carol" last="Devine">Carol Devine</name>
</author>
<author>
<name sortKey="Hons, Ba" sort="Hons, Ba" uniqKey="Hons B" first="Ba" last="Hons">Ba Hons</name>
</author>
<author>
<name sortKey="Mccollum, Charles" sort="Mccollum, Charles" uniqKey="Mccollum C" first="Charles" last="Mccollum">Charles Mccollum</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BDA3067742E82F2B63F724F14D558E2130C262CF</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1067/mva.2001.113578</idno>
<idno type="url">https://api.istex.fr/document/BDA3067742E82F2B63F724F14D558E2130C262CF/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">005925</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">005925</idno>
<idno type="wicri:Area/Istex/Curation">005925</idno>
<idno type="wicri:Area/Istex/Checkpoint">002C14</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002C14</idno>
<idno type="wicri:doubleKey">0741-5214:2001:Devine C:heparin:bonded:dacron</idno>
<idno type="wicri:Area/Main/Merge">00A364</idno>
<idno type="wicri:Area/Main/Curation">009F10</idno>
<idno type="wicri:Area/Main/Exploration">009F10</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: A multicenter trial</title>
<author>
<name sortKey="Devine, Carol" sort="Devine, Carol" uniqKey="Devine C" first="Carol" last="Devine">Carol Devine</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>South Manchester University Hospital, Department of Surgery. Manchester</wicri:regionArea>
<wicri:noRegion>Department of Surgery. Manchester</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hons, Ba" sort="Hons, Ba" uniqKey="Hons B" first="Ba" last="Hons">Ba Hons</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>South Manchester University Hospital, Department of Surgery. Manchester</wicri:regionArea>
<wicri:noRegion>Department of Surgery. Manchester</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mccollum, Charles" sort="Mccollum, Charles" uniqKey="Mccollum C" first="Charles" last="Mccollum">Charles Mccollum</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>South Manchester University Hospital, Department of Surgery. Manchester</wicri:regionArea>
<wicri:noRegion>Department of Surgery. Manchester</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Vascular Surgery</title>
<title level="j" type="abbrev">YMVA</title>
<idno type="ISSN">0741-5214</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">33</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="533">533</biblScope>
<biblScope unit="page" to="539">539</biblScope>
</imprint>
<idno type="ISSN">0741-5214</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0741-5214</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Dacron (polyester fiber) was largely abandoned for femoropopliteal bypass grafts 30 years ago because saphenous vein achieved better patencies. However, in patients taking aspirin, patency in above-knee femoropopliteal bypass grafts has recently been shown to be equivalent to that with saphenous vein. We compared heparin-bonded Dacron (HBD) and polytetrafluoroethylene (PTFE) in a randomized multicenter trial including below-knee popliteal or tibioperoneal trunk bypass graft where the long saphenous vein was absent or inadequate. Methods: Over 28 months, 209 patients undergoing femoropopliteal bypass grafts (180 above-knee, 29 below-knee) were randomized to HBD (n = 106) or PTFE (n = 103). Each patient was given aspirin (300 mg/d) before surgery, and this continued unless the patient had intolerance to the aspirin. Results: The mean follow-up was 42 months (range, 28-55). Fifteen (7.1%) patients died with patent grafts, and three (1.4%) infected grafts were removed. Patency (measured with Kaplan-Meier survival analysis) at 1, 2, and 3 years for HBD was 70%, 63%, and 55% compared with 56%, 46%, and 42%, respectively, for PTFE (P =.044). A total of 67 secondary interventions were performed on 48 thrombosed grafts; long-term patency was achieved in only three. Risk factors for arterial disease did not significantly influence patency. Amputations have been performed in 23 patients, six after HBD and 17 after PTFE bypass grafts (P =.015). Conclusions: HBD achieved better patency than PTFE, which carried a high risk of subsequent amputation. (J Vasc Surg 2001;33:533-9.)</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Devine, Carol" sort="Devine, Carol" uniqKey="Devine C" first="Carol" last="Devine">Carol Devine</name>
</noRegion>
<name sortKey="Hons, Ba" sort="Hons, Ba" uniqKey="Hons B" first="Ba" last="Hons">Ba Hons</name>
<name sortKey="Mccollum, Charles" sort="Mccollum, Charles" uniqKey="Mccollum C" first="Charles" last="Mccollum">Charles Mccollum</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009F10 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009F10 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:BDA3067742E82F2B63F724F14D558E2130C262CF
   |texte=   Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: A multicenter trial
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024